ConductScience.org, home

Paper38784367

Ibuprofen Would Be the First-Line Nonsteroidal Anti-inflammatory Drug for Polymyalgia Rheumatica: A Case Series of Five Patients.

Inokuma S and 4 others. Cureus, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Ibuprofen Would Be the First-Line Nonsteroidal Anti-inflammatory Drug for Polymyalgia Rheumatica: A Case Series of Five Patients. Papers, record 38784367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38784367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ibuprofen Would Be the First-Line Nonsteroidal Anti-inflammatory Drug for Polymyalgia Rheumatica: A Case Series of Five Patients.
PubMed
Journal
Cureus
PubMed
Year
2024
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.23, provisional
iCite
Revised in PubMed
2024-05-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Inokuma SShigeko
2Okazaki TTaro
3Morishita HHiroki
4Tsuji MMasanori
5Goto YYoshimasa

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128551169Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.Semin Arthritis Rheum2017https://conductscience.org/library/papers/28551169PubMed
234415462Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis.Clin Rheumatol2022https://conductscience.org/library/papers/34415462PubMed
333135113Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study.Infect Dis Ther2021https://conductscience.org/library/papers/33135113PubMed
437792612Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.N Engl J Med2023https://conductscience.org/library/papers/37792612PubMed
5223889962012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.Ann Rheum Dis2012https://conductscience.org/library/papers/22388996PubMed
629311081Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29311081PubMed
726535139Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review.RMD Open2015https://conductscience.org/library/papers/26535139PubMed
830285905Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer.J Immunother Cancer2018https://conductscience.org/library/papers/30285905PubMed
935635433Polymyalgia Rheumatica.Dtsch Arztebl Int2022https://conductscience.org/library/papers/35635433PubMed
1028542719Ibuprofen and diclofenac treatments reduce proliferation of pancreatic acinar cells upon inflammatory injury and mitogenic stimulation.Br J Pharmacol2018https://conductscience.org/library/papers/28542719PubMed
11518143An evaluation of criteria for polymyalgia rheumatica.Ann Rheum Dis1979https://conductscience.org/library/papers/518143PubMed
1231704799Meningitis due to non-steroidal anti-inflammatory drugs: an often-overlooked complication of a widely used medication.BMJ Case Rep2019https://conductscience.org/library/papers/31704799PubMed
1331480261Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. The Italian Case.Med Sci (Basel)2019https://conductscience.org/library/papers/31480261PubMed
1436260899Polymyalgia Rheumatica and Giant Cell Arteritis: Rapid Evidence Review.Am Fam Physician2022https://conductscience.org/library/papers/36260899PubMed
1530297332Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study.Ann Rheum Dis2018https://conductscience.org/library/papers/30297332PubMed
16301730Action of nonsteroidal, anti-inflammatory drugs on human and rat peripheral leucocyte migration in vitro.Ann Rheum Dis1977https://conductscience.org/library/papers/301730PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
40452706Oral Steroid Pulse Therapy for Polymyalgia Rheumatica.Cureus2025https://conductscience.org/library/papers/40452706

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38784367

GET https://conductscience.org/api/papers/v1/38784367/authors